Why the study?
Chronic kidney disease is associated with serious morbidity and mortality and is affected by the renin-angiotensin system, prompting evaluation of the effects of losartan on renal function in 4/6 nephrectomized rats.
Does losartan improve renal function in 4/6 nephrectomized rats?
Does losartan improve renal function in 4/6 nephrectomized rats?
Losartan (10 mg/kg/day for 1 week) significantly improved creatinine clearance and urine flow in a 4/6 nephrectomized rat model of chronic kidney disease.
Background: Chronic kidney disease associated with serious morbidity and mortality rate while it is affected by renin-angiotensin system. The effects of losartan as angiotensin II Type 1 receptor antagonist on renal functional in 4/6 nephrectomized rats was evaluated. Methods: Twenty-six male and female Wistar rats underwent 4/6 nephrectomy, and the animals from each gender were randomly divided into two groups which treated with vehicle and losartan (10 mg/kg/day for 1 week). The parameters related to kidney function were measured. Results: Creatinine (Cr) clearance and urine flow were improved in losartan-treated group significantly ( P < 0.05). The serum level of blood urea nitrogen and Cr and kidney tissue damage score and sodium urinary output (U Na V) did not alter. However, losartan decreased percentage of sodium excretion (E Na %) in both genders insignificantly. Conclusions: Losartan may improve renal function in 4/6 nephrectomized male rats.
No takes yet. Share an insight, caveat, or question.
Moeini et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: